Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use

Eugen Trinka; M Bensalem-Owen; T Grinnell; D Cantu; J Graca; J Moreira; HL Cheng; D Blum

Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use

Eugen Trinka, M Bensalem-Owen, T Grinnell, D Cantu, J Graca, J Moreira, HL Cheng, D Blum

Department of Neurology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	NEUROLOGY
Volume	90
Publication status	Published - 2018
Event	70th Annual Meeting of the American-Academy-of-Neurology (AAN) - Los Angeles, CA Duration: 21 Apr 2018 → 27 Apr 2018

Cite this

Trinka, E., Bensalem-Owen, M., Grinnell, T., Cantu, D., Graca, J., Moreira, J., Cheng, HL., & Blum, D. (2018). Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use. NEUROLOGY , 90.

Trinka, Eugen ; Bensalem-Owen, M ; Grinnell, T et al. / Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use. In: NEUROLOGY 2018 ; Vol. 90.

@article{4224f7d010cc4f6c811fec007b3b414d,

title = "Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use",

author = "Eugen Trinka and M Bensalem-Owen and T Grinnell and D Cantu and J Graca and J Moreira and HL Cheng and D Blum",

year = "2018",

language = "English",

volume = "90",

journal = "NEUROLOGY ",

issn = "0028-3878",

publisher = "Lippincott Williams & Wilkins ",

note = "70th Annual Meeting of the American-Academy-of-Neurology (AAN) ; Conference date: 21-04-2018 Through 27-04-2018",

}

Trinka, E, Bensalem-Owen, M, Grinnell, T, Cantu, D, Graca, J, Moreira, J, Cheng, HL & Blum, D 2018, 'Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use', NEUROLOGY , vol. 90.

Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use. / Trinka, Eugen; Bensalem-Owen, M; Grinnell, T et al.
In: NEUROLOGY , Vol. 90, 2018.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use

AU - Trinka, Eugen

AU - Bensalem-Owen, M

AU - Grinnell, T

AU - Cantu, D

AU - Graca, J

AU - Moreira, J

AU - Cheng, HL

AU - Blum, D

PY - 2018

Y1 - 2018

M3 - Abstract (Journal)

SN - 0028-3878

VL - 90

JO - NEUROLOGY

JF - NEUROLOGY

T2 - 70th Annual Meeting of the American-Academy-of-Neurology (AAN)

Y2 - 21 April 2018 through 27 April 2018

ER -

Trinka E, Bensalem-Owen M, Grinnell T, Cantu D, Graca J, Moreira J et al. Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use. NEUROLOGY . 2018;90.